• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[欧洲动脉粥样硬化调查III:土耳其与欧洲的比较]

[EUROASPIRE III: a comparison between Turkey and Europe].

作者信息

Tokgözoğlu Lale, Kaya Ergün Bariş, Erol Cetin, Ergene Oktay

机构信息

Hacettepe Universitesi Tip Fakültesi Kardiyoloji Anabilim Dali, Ankara, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2010 Apr;38(3):164-72.

PMID:20675993
Abstract

OBJECTIVES

The EUROASPIRE III survey was conducted in 2006-2007 in 22 countries in Europe (76 centers) to describe risk factors, lifestyle and therapeutic management of patients with coronary heart disease (CHD), compliance with current guidelines, and to document changes over time. This study aimed to assess the results of the EUROASPIRE III survey in terms of differences between Turkey and other European countries.

STUDY DESIGN

The results of the EUROASPIRE III survey were compared with those of 17 centers from Turkey. Consecutive patients with a diagnosis of CHD (669 medical records, 23.8% women) were identified retrospectively, of which 338 patients (50.5%) were followed-up, interviewed, and examined at least six months after the index event (acute coronary syndrome or interventional procedure).

RESULTS

Compared to the EUROASPIRE III data, recordings from Turkey's centers at discharge on classical risk factors did not exhibit remarkable differences; however, data on weight, height, waist circumference, lipid profile, glucose, and HbA1c measurements were more incomplete. In comparison to Europe population, the most important differences were observed in the higher rates of the following: young patients with myocardial infarction (>50 years, 20% vs. 12.7%), persistence in smoking (23.1% vs. 17.2%), immobility, low HDL-cholesterol (50.2% vs. 36.7%), insufficient follow-up by physicians after the index event (12% vs. 2.2%-except Turkey), and insufficient patient education.

CONCLUSION

The data from the Turkey arm of the survey show that efforts for cardiovascular disease prevention fall short of the targets, similar to Europe.

摘要

目的

欧洲动脉粥样硬化风险调查III(EUROASPIRE III)于2006 - 2007年在欧洲22个国家(76个中心)开展,旨在描述冠心病(CHD)患者的危险因素、生活方式及治疗管理情况,了解其对现行指南的遵循情况,并记录随时间的变化。本研究旨在评估EUROASPIRE III调查中土耳其与其他欧洲国家之间的差异结果。

研究设计

将EUROASPIRE III调查结果与来自土耳其的17个中心的结果进行比较。对确诊为CHD的连续患者(669份病历,女性占23.8%)进行回顾性识别,其中338例患者(50.5%)在索引事件(急性冠状动脉综合征或介入手术)后至少6个月接受了随访、访谈和检查。

结果

与EUROASPIRE III数据相比,土耳其各中心出院时关于经典危险因素的记录没有显著差异;然而,关于体重、身高、腰围、血脂谱、血糖和糖化血红蛋白测量的数据更不完整。与欧洲人群相比,观察到以下方面的差异最为显著:年轻心肌梗死患者比例较高(>50岁,20%对12.7%)、持续吸烟(23.1%对17.2%)、缺乏运动、高密度脂蛋白胆固醇水平低(50.2%对36.7%)、索引事件后医生随访不足(12%对2.2% - 土耳其除外)以及患者教育不足。

结论

该调查中土耳其部分的数据表明,与欧洲类似,心血管疾病预防工作未达目标。

相似文献

1
[EUROASPIRE III: a comparison between Turkey and Europe].[欧洲动脉粥样硬化调查III:土耳其与欧洲的比较]
Turk Kardiyol Dern Ars. 2010 Apr;38(3):164-72.
2
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.欧洲动脉粥样硬化调查III:对来自22个欧洲国家的冠心病患者的生活方式、风险因素及心脏保护药物治疗使用情况的调查。
Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.
3
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.来自15个国家的冠心病患者的生活方式、危险因素管理及药物治疗的应用;欧洲心脏调查项目EUROASPIRE II的主要结果
Eur Heart J. 2001 Apr;22(7):554-72. doi: 10.1053/euhj.2001.2610.
4
Management of overweight and obese patients with coronary heart disease across Europe.欧洲冠心病超重及肥胖患者的管理
Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):447-54. doi: 10.1097/HJR.0b013e328336a05f.
5
Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.欧洲各地冠心病患者的血压控制情况和目标血压知识:来自 EUROASPIRE III 调查的结果。
J Hypertens. 2011 Aug;29(8):1641-8. doi: 10.1097/HJH.0b013e328348efa7.
6
[Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].[冠心病的二级预防。德国明斯特地区EuroASPIRE I和II研究结果]
Dtsch Med Wochenschr. 2002 Mar 29;127(13):667-72. doi: 10.1055/s-2002-23480.
7
The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.捷克冠心病患者二级预防目标的探索。欧洲心脏调查Ⅰ和Ⅱ的比较。
Cent Eur J Public Health. 2002 Sep;10(3):107-11.
8
Management of coronary artery disease in Kyrgyzstan: a comparison with Turkey and europe according to European Action on Primary and secondary prevention by intervention to reduce events III results.吉尔吉斯斯坦冠状动脉疾病的管理:根据欧洲通过干预进行一级和二级预防以减少事件III的结果与土耳其及欧洲的比较。
Turk Kardiyol Dern Ars. 2014 Sep;42(6):545-52. doi: 10.5543/tkda.2014.97254.
9
Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey.
Eur Heart J. 1999 Nov;20(22):1630-7. doi: 10.1053/euhj.1999.1635.
10
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.日常实践中的心血管疾病预防指南:八个欧洲国家的EUROASPIRE I、II和III调查比较
Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.

引用本文的文献

1
Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.初治个体对胆固醇及降脂药物的认知与了解:一项横断面研究
Patient Prefer Adherence. 2025 May 13;19:1411-1422. doi: 10.2147/PPA.S511454. eCollection 2025.
2
Prevalence of Cardiovascular Disease and Comparison of Risk Category Predictions of Systemic Coronary Risk Evaluation Score-2 and 4 Other Cardiovascular Disease Risk Assessment Tools Among People Living with Human Immunodefficiency Virus in Türkiye.土耳其人类免疫缺陷病毒感染者心血管疾病患病率及系统性冠状动脉风险评估评分-2与其他4种心血管疾病风险评估工具风险类别预测的比较
Anatol J Cardiol. 2024 Oct 18;28(12):584-91. doi: 10.14744/AnatolJCardiol.2024.4558.
3
The secondary prevention of coronary heart disease in US adults 75 Years and older in daily practice: Results from the National Health and Nutrition Examination Survey 1999-2018 survey.美国75岁及以上成年人日常实践中冠心病的二级预防:1999 - 2018年国家健康与营养检查调查结果
Heliyon. 2024 Mar 21;10(7):e28239. doi: 10.1016/j.heliyon.2024.e28239. eCollection 2024 Apr 15.
4
Does fear of activity predict exercise capacity in patients with coronary artery disease in both sexes? A cross-sectional multicenter study.对活动的恐惧能否预测冠心病患者(无论男女)的运动能力?一项横断面多中心研究。
Turk J Phys Med Rehabil. 2024 Feb 1;70(1):73-80. doi: 10.5606/tftrd.2024.12956. eCollection 2024 Mar.
5
Kinesiophobia, physical performance, and health-related quality of life in patients with coronary artery disease.冠心病患者的运动恐惧、身体表现及健康相关生活质量
Postepy Kardiol Interwencyjnej. 2022 Sep;18(3):246-254. doi: 10.5114/aic.2022.122892. Epub 2022 Dec 17.
6
Demographic, Clinical, and Angiographic Characteristics of Atrial Fibrillation Patients Suffering From de novo Acute Myocardial Infarction: A Subgroup Analysis of the MINOCA-TR Study Population.初发急性心肌梗死的心房颤动患者的人口统计学、临床和血管造影特征:MINOCA-TR研究人群的亚组分析
J Atr Fibrillation. 2021 Apr 30;13(6):20200468. doi: 10.4022/jafib.20200468. eCollection 2021 Apr-May.
7
The landscape of preventive cardiology in Turkey: Challenges and successes.土耳其预防心脏病学的现状:挑战与成就
Am J Prev Cardiol. 2021 Apr 14;6:100184. doi: 10.1016/j.ajpc.2021.100184. eCollection 2021 Jun.
8
Prevalence and clinical profile of patients with myocardial infarction with non-obstructive coronary arteries in Turkey (MINOCA-TR): A national multi-center, observational study.土耳其非阻塞性冠状动脉心肌梗死患者的患病率及临床特征(MINOCA-TR):一项全国多中心观察性研究
Anatol J Cardiol. 2020 Feb;23(3):176-182. doi: 10.14744/AnatolJCardiol.2019.46805.
9
The real-life data of hospitalized patients with heart failure: On behalf of the Journey HF-TR study investigators.心力衰竭住院患者的真实世界数据:代表“心衰之旅-真实世界研究”的研究者们。
Anatol J Cardiol. 2019 Jan;21(1):25-30. doi: 10.14744/AnatolJCardiol.2018.50880.
10
Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study.土耳其老年人群的冠心病二级预防:ELDERTURK 研究的亚组分析。
Cardiol J. 2019;26(1):13-19. doi: 10.5603/CJ.a2017.0113. Epub 2017 Oct 5.